170 related articles for article (PubMed ID: 17186003)
1. Selective AT1 receptor antagonism enhances sympathetically mediated vasoconstriction in man.
Lyons D; Jackson SH; Swift CG
Clin Pharmacol Ther; 2007 Jan; 81(1):83-7. PubMed ID: 17186003
[TBL] [Abstract][Full Text] [Related]
2. Effect of the non peptide angiotensin II antagonist, GR117289C on the vasoconstrictor actions of angiotensin II in the human forearm.
Lyons D; Webster J; Nixon A; Young MM; Smith J; Benjamin N
Br J Clin Pharmacol; 1997 Mar; 43(3):323-6. PubMed ID: 9088589
[TBL] [Abstract][Full Text] [Related]
3. Effects of the angiotensin type I receptor antagonist, losartan, on systemic and regional vascular responses to lower body negative pressure in healthy volunteers.
Duranteau J; Pussard E; Berdeaux A; Giudicelli JF
Br J Clin Pharmacol; 1995 Nov; 40(5):431-8. PubMed ID: 8703646
[TBL] [Abstract][Full Text] [Related]
4. The angiotensin II receptor antagonist valsartan inhibits endothelin 1-induced vasoconstriction in the skin microcirculation in humans in vivo: influence of the G-protein beta3 subunit (GNB3) C825T polymorphism.
Mitchell A; Rushentsova U; Siffert W; Philipp T; Wenzel RR
Clin Pharmacol Ther; 2006 Mar; 79(3):274-81. PubMed ID: 16513451
[TBL] [Abstract][Full Text] [Related]
5. ACE inhibition: postsynaptic adrenergic sympatholytic action in men.
Lyons D; Roy S; O'Byrne S; Swift CG
Circulation; 1997 Aug; 96(3):911-5. PubMed ID: 9264500
[TBL] [Abstract][Full Text] [Related]
6. Endogenous angiotensin II does not contribute to sympathetic venoconstriction in dorsal hand veins of healthy humans.
Masumori S; Newby DE; Strachan FE; Boon NA; Webb DJ
Clin Pharmacol Ther; 1997 Sep; 62(3):327-33. PubMed ID: 9333109
[TBL] [Abstract][Full Text] [Related]
7. Statin therapy increases vascular sensitivity to angiotensin II in hypercholesterolaemic patients.
Sim JS; Dick JB; Struthers AD
J Renin Angiotensin Aldosterone Syst; 2004 Sep; 5(3):109-13. PubMed ID: 15526245
[TBL] [Abstract][Full Text] [Related]
8. B1 kinin receptor does not contribute to vascular tone or tissue plasminogen activator release in the peripheral circulation of patients with heart failure.
Cruden NL; Tse GH; Fox KA; Ludlam CA; Megson I; Newby DE
Arterioscler Thromb Vasc Biol; 2005 Apr; 25(4):772-7. PubMed ID: 15681300
[TBL] [Abstract][Full Text] [Related]
9. Tonic levels of angiotensin II reduce tonic levels of vascular nitric oxide even in salt-replete man.
Sim JS; Farquharson C; Struthers AD
J Renin Angiotensin Aldosterone Syst; 2004 Jun; 5(2):84-8. PubMed ID: 15295720
[TBL] [Abstract][Full Text] [Related]
10. Endogenous angiotensin II contributes to basal peripheral vascular tone in sodium deplete but not sodium replete man.
Newby DE; Masumori S; Johnston NR; Boon NA; Webb DJ
Cardiovasc Res; 1997 Nov; 36(2):268-75. PubMed ID: 9463638
[TBL] [Abstract][Full Text] [Related]
11. Angiotensin AT1 receptor blockade abolishes the reflex sympatho-excitatory response to adenosine.
Rongen GA; Brooks SC; Ando Si; Abramson BL; Floras JS
J Clin Invest; 1998 Feb; 101(4):769-76. PubMed ID: 9466971
[TBL] [Abstract][Full Text] [Related]
12. Influence of indomethacin and L-NMMA on vascular tone and angiotensin II-induced vasoconstriction in the human forearm.
Baan J; Chang PC; Vermeij P; Pfaffendorf M; van Zwieten PA
Blood Press; 1997 Sep; 6(5):279-85. PubMed ID: 9359998
[TBL] [Abstract][Full Text] [Related]
13. The effect of intra-arterial endothelin on resting blood flow and sympathetically mediated vasoconstriction in the forearm of man.
Cockcroft JR; Clarke JG; Webb DJ
Br J Clin Pharmacol; 1991 May; 31(5):521-4. PubMed ID: 1888618
[TBL] [Abstract][Full Text] [Related]
14. Regulation of peripheral vascular tone in patients with heart failure: contribution of angiotensin II.
Newby DE; Goodfield NE; Flapan AD; Boon NA; Fox KA; Webb DJ
Heart; 1998 Aug; 80(2):134-40. PubMed ID: 9813557
[TBL] [Abstract][Full Text] [Related]
15. Effects of losartan on vasoconstrictor responses to angiotensin II in the forearm vascular bed of healthy volunteers.
Baan J; Chang PC; Vermeij P; Pfaffendorf M; van Zwieten PA
Cardiovasc Res; 1996 Nov; 32(5):973-9. PubMed ID: 8944829
[TBL] [Abstract][Full Text] [Related]
16. Urotensin II evokes potent vasoconstriction in humans in vivo.
Böhm F; Pernow J
Br J Pharmacol; 2002 Jan; 135(1):25-7. PubMed ID: 11786476
[TBL] [Abstract][Full Text] [Related]
17. Effect of eprosartan on catecholamines and peripheral haemodynamics in subjects with insulin-induced hypoglycaemia.
Christensen M; Ibsen H; Worck R
Clin Sci (Lond); 2005 Feb; 108(2):113-9. PubMed ID: 15383007
[TBL] [Abstract][Full Text] [Related]
18. Comparison of angiotensin-converting enzyme inhibition with angiotensin II receptor antagonism in the human forearm.
Cockcroft JR; Sciberras DG; Goldberg MR; Ritter JM
J Cardiovasc Pharmacol; 1993 Oct; 22(4):579-84. PubMed ID: 7505360
[TBL] [Abstract][Full Text] [Related]
19. Losartan attenuates renal vasoconstriction in response to acute unilateral ureteral occlusion in pigs.
Hvistendahl JJ; Pedersen TS; Djurhuus JC; Pedersen EB; Frøkiaer J
Urol Res; 2002 Jul; 30(3):169-77. PubMed ID: 12111180
[TBL] [Abstract][Full Text] [Related]
20. Verapamil and alpha-mediated vasoconstriction in human forearm: a comparison between norepinephrine and selective alpha 1- and alpha 2-adrenergic agonists.
Pedrinelli R; Taddei S; Graziadei L; Pana-Race G; Salvetti A
J Cardiovasc Pharmacol; 1987; 10 Suppl 10():S48-52. PubMed ID: 2455139
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
